Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05363306 |
Other study ID # |
TLMBS |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 1, 2021 |
Est. completion date |
March 1, 2022 |
Study information
Verified date |
May 2022 |
Source |
International Piezosurgery Academy |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
early marginal bone loss around dental implants may hamper long term prognosis of
implant-prosthetic rehabilitation. this study aimed to study the correlation of pico-coronal
position of dental implant (from supracrestal, crystal to undergone level) measuring early
marginal bone loss through periapical x-ray at surgical time and subsequent follow-ups.
Description:
Early marginal bone loss (EMBL) is a non-infective remodeling process of peri-implant crestal
bone occurring within the first year after implant insertion. EMBL has a multifactorial
etiology, being influenced by various surgical and prosthetic factors, including insufficient
crestal width, surgical trauma, biological width formation, microbial colonization of
implant-abutment micro-gap, horizontal implant-abutment mismatch ("the platform-switching
concept"), the number of abutment connection/disconnections, prosthetic abutment height,
design and mechanical stability of implant-abutment connection and adaptive response to
occlusal loading.
Biological width formation is the main factor influencing peri-implant marginal bone adaptive
processes prior to prosthesis delivery. When an implant gets exposed to the oral cavity, soft
tissues establish a cuff-like barrier sealing the trans-epithelial component of the fixture.
Differently from equicrestal and subcrestal implants, which present a microgap between
implant and abutment at the marginal bone level, tissue-level implants have no gap at this
region.
The present multicenter prospective study aims to evaluate if EMBL occurring around
tissue-level dental implants before prosthesis delivery may be reduced by adapting
apico-coronal positioning in relation to supracrestal tissue thickness.
All patients are treated according to one-stage implant. Sutures are removed 12-14 days after
surgery. No removable prostheses are utilized during the healing period.
Final impressions were taken five months after the implant placement. After functional and
aesthetic try-in, a single-unit screw-retained metal ceramic crown is delivered. The fixation
screw was torqued to 30Ncm following manufacturer's guidelines. Screw access is then closed
using light-cured composite resin.
Radiographic measurements. Digital radiographs, customized for each patient with a bite jig,
are taken using a long-cone paralleling technique with a film holder at the time of implant
placement (baseline, T0), 3 months after implant placement (T1), and 5 months after implant
placement, immediately before impression taking (T2). All radiographs are performed using the
same x-ray generator technology, set with the same parameters (60 kV, 7 mA).
Two different types of bone changes are calculated, as suggested elsewhere.
1. Early marginal bone loss (EMBL) is calculated.
2. Bone Loss Exposing Implant Surface (BLEIS) is calculated as the difference between the
EMBL measurement and the 3 mm length of the transmucosal, machined portion of the
implant.
Radiographs demonstrating any deformation, darkness and/or other problem are immediately
repeated. All measurements are made by a single calibrated examiner, blind to mucosal
thickness, using a 30-inch led-backlit color diagnostic display with Kodak Digital Imaging
Software. Each measurement is repeated three times at three different time points as proposed
by Gomez-Roman and Launer. Intra-examiner and inter-examiner concordances are 96.1% and
90.4%, respectively, for linear measurements within ±0.1mm.